Cargando…

Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats

BACKGROUND: Mast cells (MCs) are implicated in inflammation and tissue remodeling. Accumulation of lung MCs is described in pulmonary hypertension (PH); however, whether MC degranulation and c-kit, a tyrosine kinase receptor critically involved in MC biology, contribute to the pathogenesis and progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahal, Bhola K, Kosanovic, Djuro, Kaulen, Christina, Cornitescu, Teodora, Savai, Rajkumar, Hoffmann, Julia, Reiss, Irwin, Ghofrani, Hossein A, Weissmann, Norbert, Kuebler, Wolfgang M, Seeger, Werner, Grimminger, Friedrich, Schermuly, Ralph T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104382/
https://www.ncbi.nlm.nih.gov/pubmed/21535881
http://dx.doi.org/10.1186/1465-9921-12-60
_version_ 1782204601682886656
author Dahal, Bhola K
Kosanovic, Djuro
Kaulen, Christina
Cornitescu, Teodora
Savai, Rajkumar
Hoffmann, Julia
Reiss, Irwin
Ghofrani, Hossein A
Weissmann, Norbert
Kuebler, Wolfgang M
Seeger, Werner
Grimminger, Friedrich
Schermuly, Ralph T
author_facet Dahal, Bhola K
Kosanovic, Djuro
Kaulen, Christina
Cornitescu, Teodora
Savai, Rajkumar
Hoffmann, Julia
Reiss, Irwin
Ghofrani, Hossein A
Weissmann, Norbert
Kuebler, Wolfgang M
Seeger, Werner
Grimminger, Friedrich
Schermuly, Ralph T
author_sort Dahal, Bhola K
collection PubMed
description BACKGROUND: Mast cells (MCs) are implicated in inflammation and tissue remodeling. Accumulation of lung MCs is described in pulmonary hypertension (PH); however, whether MC degranulation and c-kit, a tyrosine kinase receptor critically involved in MC biology, contribute to the pathogenesis and progression of PH has not been fully explored. METHODS: Pulmonary MCs of idiopathic pulmonary arterial hypertension (IPAH) patients and monocrotaline-injected rats (MCT-rats) were examined by histochemistry and morphometry. Effects of the specific c-kit inhibitor PLX and MC stabilizer cromolyn sodium salt (CSS) were investigated in MCT-rats both by the preventive and therapeutic approaches. Hemodynamic and right ventricular hypertrophy measurements, pulmonary vascular morphometry and analysis of pulmonary MC localization/counts/activation were performed in animal model studies. RESULTS: There was a prevalence of pulmonary MCs in IPAH patients and MCT-rats as compared to the donors and healthy rats, respectively. Notably, the perivascular MCs were increased and a majority of them were degranulated in lungs of IPAH patients and MCT-rats (p < 0.05 versus donor and control, respectively). In MCT-rats, the pharmacological inhibitions of MC degranulation and c-kit with CSS and PLX, respectively by a preventive approach (treatment from day 1 to 21 of MCT-injection) significantly attenuated right ventricular systolic pressure (RVSP) and right ventricular hypertrophy (RVH). Moreover, vascular remodeling, as evident from the significantly decreased muscularization and medial wall thickness of distal pulmonary vessels, was improved. However, treatments with CSS and PLX by a therapeutic approach (from day 21 to 35 of MCT-injection) neither improved hemodynamics and RVH nor vascular remodeling. CONCLUSIONS: The accumulation and activation of perivascular MCs in the lungs are the histopathological features present in clinical (IPAH patients) and experimental (MCT-rats) PH. Moreover, the accumulation and activation of MCs in the lungs contribute to the development of PH in MCT-rats. Our findings reveal an important pathophysiological insight into the role of MCs in the pathogenesis of PH in MCT- rats.
format Text
id pubmed-3104382
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31043822011-06-01 Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats Dahal, Bhola K Kosanovic, Djuro Kaulen, Christina Cornitescu, Teodora Savai, Rajkumar Hoffmann, Julia Reiss, Irwin Ghofrani, Hossein A Weissmann, Norbert Kuebler, Wolfgang M Seeger, Werner Grimminger, Friedrich Schermuly, Ralph T Respir Res Research BACKGROUND: Mast cells (MCs) are implicated in inflammation and tissue remodeling. Accumulation of lung MCs is described in pulmonary hypertension (PH); however, whether MC degranulation and c-kit, a tyrosine kinase receptor critically involved in MC biology, contribute to the pathogenesis and progression of PH has not been fully explored. METHODS: Pulmonary MCs of idiopathic pulmonary arterial hypertension (IPAH) patients and monocrotaline-injected rats (MCT-rats) were examined by histochemistry and morphometry. Effects of the specific c-kit inhibitor PLX and MC stabilizer cromolyn sodium salt (CSS) were investigated in MCT-rats both by the preventive and therapeutic approaches. Hemodynamic and right ventricular hypertrophy measurements, pulmonary vascular morphometry and analysis of pulmonary MC localization/counts/activation were performed in animal model studies. RESULTS: There was a prevalence of pulmonary MCs in IPAH patients and MCT-rats as compared to the donors and healthy rats, respectively. Notably, the perivascular MCs were increased and a majority of them were degranulated in lungs of IPAH patients and MCT-rats (p < 0.05 versus donor and control, respectively). In MCT-rats, the pharmacological inhibitions of MC degranulation and c-kit with CSS and PLX, respectively by a preventive approach (treatment from day 1 to 21 of MCT-injection) significantly attenuated right ventricular systolic pressure (RVSP) and right ventricular hypertrophy (RVH). Moreover, vascular remodeling, as evident from the significantly decreased muscularization and medial wall thickness of distal pulmonary vessels, was improved. However, treatments with CSS and PLX by a therapeutic approach (from day 21 to 35 of MCT-injection) neither improved hemodynamics and RVH nor vascular remodeling. CONCLUSIONS: The accumulation and activation of perivascular MCs in the lungs are the histopathological features present in clinical (IPAH patients) and experimental (MCT-rats) PH. Moreover, the accumulation and activation of MCs in the lungs contribute to the development of PH in MCT-rats. Our findings reveal an important pathophysiological insight into the role of MCs in the pathogenesis of PH in MCT- rats. BioMed Central 2011 2011-05-02 /pmc/articles/PMC3104382/ /pubmed/21535881 http://dx.doi.org/10.1186/1465-9921-12-60 Text en Copyright ©2011 Dahal et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Dahal, Bhola K
Kosanovic, Djuro
Kaulen, Christina
Cornitescu, Teodora
Savai, Rajkumar
Hoffmann, Julia
Reiss, Irwin
Ghofrani, Hossein A
Weissmann, Norbert
Kuebler, Wolfgang M
Seeger, Werner
Grimminger, Friedrich
Schermuly, Ralph T
Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
title Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
title_full Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
title_fullStr Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
title_full_unstemmed Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
title_short Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
title_sort involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104382/
https://www.ncbi.nlm.nih.gov/pubmed/21535881
http://dx.doi.org/10.1186/1465-9921-12-60
work_keys_str_mv AT dahalbholak involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats
AT kosanovicdjuro involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats
AT kaulenchristina involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats
AT cornitescuteodora involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats
AT savairajkumar involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats
AT hoffmannjulia involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats
AT reissirwin involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats
AT ghofranihosseina involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats
AT weissmannnorbert involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats
AT kueblerwolfgangm involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats
AT seegerwerner involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats
AT grimmingerfriedrich involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats
AT schermulyralpht involvementofmastcellsinmonocrotalineinducedpulmonaryhypertensioninrats